Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: Specificity in prostate and non-prostate cell lines

Journal of Molecular Endocrinology

Volumn 25, Issue 1, 2000, Pages 85-96

  Beilin, J ^a   Ball, E M A ^a   Favaloro, J M ^a   Zajac, J D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; GENETIC POLYMORPHISM; NONHUMAN; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; TRANSCRIPTION REGULATION;

EID: 0033867110     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0250085     Document Type: Article

References (42)

1. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
2. Receptor stares and subsequent sensitivity of subclones of MCF-7 human breast cancer cells surviving exposure to diethylstilbestrol
3. Relative activity and specificity of promoters from prostate-expressed genes
4. Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system
5. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function
6. Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain
7. Reduced androgen receptor gene expression with first exon CAG repeat expansion
8. The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors
9. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter
10. The N-terminal domain of the human androgen receptor is encoded by one large exon
11. Transcriptional activation and transient expression of the human androgen receptor
12. A single amino acid exchange abolishes dimerization of the androgen receptor and causes Reifenstein syndrome
13. N-terminal sequences of the human androgen receptor in DNA binding and transrepressing functions
14. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
15. The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia
16. Nuclear receptor coactivators
17. SV40-transformed simian cells support the replication of early SV40 mutants
18. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice
19. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer
20. Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells
21. Androgen receptor CAG repeat lengths in prostate cancer: Correlation with age of onset
22. LNCaP model of human prostatic carcinoma
23. The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator
24. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor (see comments)
25. Functional domains of the human androgen receptor
26. Changes in the abundance of androgen receptor isotypes effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites
27. Identification of two transcription activation units in the N-terminal domain of the human androgen receptor
28. Establishment and characterization of a human prostatic carcinoma cell line (PC-3)
29. Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene
30. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: Possible pathogenetic relevance for the (CAG)n-expanded neuronopathies
31. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
32. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy
33. Transcriptional activation by the androgen receptor in X-linked spinal and bulbar muscular atrophy
34. CAG-repeat expansion in androgen receptor in Kennedy's disease is not a loss of function mutation
35. Luciferase reporter gene vectors for analysis of promoters and enhancers
36. Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region
37. Androgen receptor localization in different cell types of the adult rat prostate
38. Androgen receptor defects: Historical, clinical, and molecular perspectives
39. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene
40. Accomplishments in Cancer Research
41. Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation
42. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility